Physician profile
Howard M Hack
NPI 1952483786
$1,501.70
in general payments reported to CMS, 2019-2025
20 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $267 · 2021: $430 · 2022: $451 · 2023: $95.93 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $525.59 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $172.42 | 2020-2023 | Xifaxan |
| Conmed Corporation | $115.69 | 2025 | Conmed Biliary |
| Intercept Pharmaceuticals, INC. | $114.25 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.98 | 2019-2022 | |
| Janssen Biotech, INC. | $79.45 | 2020-2023 | Stelara |
| Gilead Sciences, INC. | $70.07 | 2021-2022 | |
| Pfizer INC. | $54.89 | 2019-2021 | |
| Braintree Laboratories, INC. | $48.81 | 2021-2022 | |
| Celgene Corporation | $34.31 | 2021-2023 | |
| Qol Medical, LLC | $29.65 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.32 | 2022 | |
| Genzyme Corporation | $20.82 | 2022 | |
| Shire North American Group INC | $15.80 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $15.62 | 2020 | |
| Medtronic, INC. | $15.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.06 | 2022 | |
| Alfasigma USA, INC. | $12.63 | 2020 | |
| Nestle Healthcare Nutrition INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Hack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.